Canal Insurance CO Bristol Myers Squibb CO Call Options Transaction History

Canal Insurance CO

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 01, 2024	BUY	$40.25 - $52.99 $12,075 - $15,897	300 New	300 $39,000
Q1 2022 Apr 22, 2022	SELL	$61.48 - $73.72 $3.04 Million - $3.65 Million	-49,525 Reduced 99.05%	475 $321,000
Q3 2019 Oct 24, 2019	SELL	$42.77 - $50.71 $213,850 - $253,550	-5,000 Reduced 9.09%	50,000 $68,000
Q2 2018 Aug 10, 2018	SELL	$50.53 - $62.98 $3.54 Million - $4.41 Million	-70,000 Reduced 56.0%	55,000 $95,000
Q1 2018 May 03, 2018	BUY	$59.92 - $68.98 $3.6 Million - $4.14 Million	60,000 Added 92.31%	125,000 $0
Q4 2017 Jan 31, 2018	BUY	$59.94 - $65.35 $299,700 - $326,750	5,000 Added 8.33%	65,000 $93,000
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $3.31 Million - $3.82 Million	60,000	60,000 $0

2,402

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $110B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Canal Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Canal Insurance CO with notifications on news.